ALPMF - Apellis gets EU snub for eye therapy
2024-01-26 07:39:18 ET
More on Apellis Pharmaceuticals
- Apellis Pharmaceuticals: Focus Shifts Toward Market Share After Apparent Safety Resolution
- Apellis Pharmaceuticals, Inc. (APLS) Q3 2023 Earnings Call Transcript
- Apellis Pharmaceuticals, Inc. 2023 Q3 - Results - Earnings Call Presentation
- Apellis Pharmaceuticals announces Q4 U.S. net product revenues
- Apellis falls on potential EU snub for eye therapy (update)